Qinjie Y. Weng

Hangzhou, 310058, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 103 publications

Advances in mechanical signal-regulated tumor immunity and its therapeutic development

Advances in mechanical signal-regulated tumor immunity and its therapeutic development

Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences

Published: August 28, 2026

Discovery of Novel Trisubstituted Pyridine Derivatives as EED-H3K27me3 Inhibitors for the Treatment of Multiple Sclerosis.

Discovery of Novel Trisubstituted Pyridine Derivatives as EED-H3K27me3 Inhibitors for the Treatment of Multiple Sclerosis.

Journal: Journal of medicinal chemistry

Published: March 18, 2026

Correction to "Global PROTAC Toolbox for Degrading BCR-ABL Overcomes Drug Resistant Mutants and Adverse Effects".

Correction to "Global PROTAC Toolbox for Degrading BCR-ABL Overcomes Drug Resistant Mutants and Adverse Effects".

Journal: Journal of medicinal chemistry

Published: February 01, 2026

Discovery of Novel Nonsteroidal SGRMs of Sulfonamide-2-Oxo-Tetrahydroquinoline Derivatives by Carbonyl Migration.

Discovery of Novel Nonsteroidal SGRMs of Sulfonamide-2-Oxo-Tetrahydroquinoline Derivatives by Carbonyl Migration.

Journal: Journal of medicinal chemistry

Published: January 06, 2026

Telitacicept in IgA Nephropathy Patients with Severe Renal Impairment: A Case Series.

Telitacicept in IgA Nephropathy Patients with Severe Renal Impairment: A Case Series.

Journal: Kidney diseases (Basel, Switzerland)

Published: December 24, 2025

A Newly Designed Antibody-drug Conjugate Targeting B7-H3 Demonstrates Enhanced Therapeutic Efficacy Across a Spectrum of Cancers.

A Newly Designed Antibody-drug Conjugate Targeting B7-H3 Demonstrates Enhanced Therapeutic Efficacy Across a Spectrum of Cancers.

Journal: Pharmaceutical research

Published: December 17, 2025

Few-shot learning-driven discovery of Lutein suppresses Th1-mediated inflammation via glucose metabolism.

Few-shot learning-driven discovery of Lutein suppresses Th1-mediated inflammation via glucose metabolism.

Journal: Acta pharmacologica Sinica

Published: October 12, 2025

Osimertinib activates TFEB to trigger hepatocyte cytoplasmic vacuolation-associated cell death.

Osimertinib activates TFEB to trigger hepatocyte cytoplasmic vacuolation-associated cell death.

Journal: Cell communication and signaling : CCS

Published: September 08, 2025

Telitacicept targets Gd-IgA1 and autoantibody-producing B cells in IgA nephropathy.

Telitacicept targets Gd-IgA1 and autoantibody-producing B cells in IgA nephropathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: September 07, 2025

Dapagliflozin Reduces Kidney Inflammation in Alport Syndrome by Inhibiting the Stimulator of IFN Genes Pathway in Renal Tubular Epithelial Cells.

Dapagliflozin Reduces Kidney Inflammation in Alport Syndrome by Inhibiting the Stimulator of IFN Genes Pathway in Renal Tubular Epithelial Cells.

Journal: Kidney360

Published: August 21, 2025

AI-driven pipeline discovers ombuin as a novel M1 macrophage polarization inhibitor for sepsis treatment.

AI-driven pipeline discovers ombuin as a novel M1 macrophage polarization inhibitor for sepsis treatment.

Journal: Acta pharmacologica Sinica

Published: August 18, 2025

Lithospermum erythrorhizon extract alleviates immunosuppression via MAPK signaling pathway.

Lithospermum erythrorhizon extract alleviates immunosuppression via MAPK signaling pathway.

Journal: Frontiers in veterinary science

Published: June 26, 2025

Showing 1-12 of 103

Last Updated: 09/26/2026